Recurrent miscarriage: Pathophysiology and outcome

Current Opinion in Obstetrics and Gynecology

Volumn 17, Issue 6, 2005, Pages 591-597

  Carrington, Belinda ^a   Sacks, Gavin ^a   Regan, Lesley ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Cytokines; Insulin resistance; Miscarriage; Natural killer cells; Preimplantation genetic diagnosis; Thrombophilias

Indexed keywords

ACETYLSALICYLIC ACID; BLOOD CLOTTING FACTOR 5 LEIDEN; CD56 ANTIGEN; ENOXAPARIN; FIBRINOGEN; HEPARIN; IMMUNOGLOBULIN; INSULIN SENSITIZING AGENT; LOW MOLECULAR WEIGHT HEPARIN; METFORMIN; PHOSPHOLIPID ANTIBODY; PLACENTA PROTEIN 14; SOMATOMEDIN BINDING PROTEIN; STEROID; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ANTIPHOSPHOLIPID SYNDROME; CELLULAR IMMUNITY; CHROMOSOME ABERRATION; CLINICAL TRIAL; ENDOMETRIUM; FERTILIZATION IN VITRO; GENETIC SCREENING; HEMOSTASIS; HUMAN; HYPOFIBRINOGENEMIA; IMMUNE SYSTEM; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MOTHER FETUS RELATIONSHIP; NATURAL KILLER CELL; NIDATION; OBESITY; OVARY POLYCYSTIC DISEASE; PATHOGENESIS; PREGNANCY COMPLICATION; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; PROPHYLAXIS; RECURRENT ABORTION; REVIEW; ROBERTSONIAN CHROMOSOME TRANSLOCATION; THROMBOELASTOGRAPHY; THROMBOPHILIA; THROMBOSIS PREVENTION;

EID: 27844555339     PISSN: 1040872X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.gco.0000194112.86051.26     Document Type: Review

References (84)

1. Clifford K, Rai R, Regan L. Future pregnancy outcome in unexplained recurrent first trimester miscarriage. Hum Reprod 1997; 12:387-389.
2. Sugiura-Ogasawara M, Ozaki Y, Sato T, Suzumori N, Suzumori K. Poor prognosis of recurrent aborters with either maternal or paternal reciprocal translocations. Fertil Steril 2004; 81:367-373. This study shows a poorer outcome for couples with reciprocal translocations compared with controls, and that the rate of unbalanced translocation in their offspring is 2.9%.
3. Verlinsky Y, Cohen J, Munne S, et al. Over a decade of experience with preimplantation genetic diagnosis: a multicenter report. Fertil Steril 2004; 82:292-294. This large, long-term, multicentre study showed results of preimplantation genetic diagnosis for structural, single gene, and other genetic disorders.
4. Carp HJ, Dirnfeld M, Dor J, Grudzinskas JG. ART in recurrent miscarriage: preimplantation genetic diagnosis/screening or surrogacy? Hum Reprod 2004; 19:1502-1505. This article discusses the application of preimplantation genetic diagnosis and surrogacy for recurrent miscarriage of different causes.
5. Rubio C, Simon C, Vidal F, et al. Chromosomal abnormalities and embryo development in recurrent miscarriage couples. Hum Reprod 2003; 18:182-188.
6. Goddijn M, Joosten JHK, Knegt AC, et al. Clinical relevance of diagnosing structural chromosome abnormalities in couples with repeated miscarriage. Hum Reprod 2004; 19:1013-1017. Unlike Sugiura-Ogasawara et al. [2] this smaller study group did not find any unbalanced offspring from couples carrying chromosomal abnormalities with recurrent misscarriage.
7. Carp HJA, Feldman B, Oelsner G, et al. Parental karyotype and subsequent live births in recurrent miscarriage. Fertil Steril 2004; 81:1296-1301. This is one of the studies showing that the subsequent live birth rate among couples with recurrent misscarriage and structural chromosomal abnormalities is similar to that in couples without abnormalities.
8. Ogasawara M, Aoki K, Okada S, Suzumori K. Embryonic karyotype of abortuses in relation to the number of previous miscarriages. Fertil Steril 2000; 73:300-304.
9. Kupfermine MJ. Thrombophilia and pregnancy. Reprod Biol Endocrinol 2003; 1:111.
10. Rey E, Kahn SR, David M, Shrier I. Thrombophilic disorders and fetal loss: a meta-analysis. Lancet 2003; 361:901-908.
11. Roque H, Paidas MJ, Funai EF, et al. Maternal thrombophilias are not associated with early pregnancy loss. Thromb Haemost 2004; 91:290-295. This study shows that maternal thrombophilia is only associated with pregnancy losses after 14 weeks (n = 491).
12. Rasmussen A, Ravn P. High frequency of congenital thrombophilia in women with pathological pregnancies? Acta Obstet Gynecol Scand 2004; 83: 808-817. This review did not find an association between maternal thrombophilia and early pregnancy loss.
13. Kujovich JL. Thrombophilia and pregnancy complications. Am J Obstet Gynecol 2004; 191:412-424. This systematic review found that thrombophilia is associated with increased risk for losses in all trimesters, although there is greater strength of association for second and third trimester loss than for first trimester loss.
14. Rai R, Backos M, Elgaddal S, et al. Factor V Leiden and recurrent miscarriage: prospective outcome of untreated pregnancies. Hum Reprod 2002; 17: 442-445.
15. Dudding TE, Attia J. The association between adverse pregnancy outcomes and maternal factor V Leiden genotype: a meta-analysis. Thromb Haemost 2004; 91:700-711. This analysis shows that there is a stronger association between FVL mutation and second/third trimester losses than with first trimester losses.
16. Sikkema JM, Franx A, Bruinse HW, et al. Placental pathology in early onset pre-eclampsia and intra-uterine growth restriction in women with and without thrombophilia. Placenta 2002; 23:337-342.
17. Morssink LP, Santema JG, Willemse F. Thrombophilia is not associated with an increase in placental abnormalities in women with intrauterine fetal death. Obstet Gynecol Surv 2004; 59:566-567. This study also looked at birthweight, gestational age at delivery and case-controlled placental abruption, and found no differences between the thrombophilic women and those without thrombophilias in these parameters.
18. Brenner B. Antithrombotic prophylaxis for women with thrombophilia and pregnancy complications - yes. J Thromb Haemost 2003; 1:2070-2072.
19. Carp H, Dolitzky M, Inbal A. Thromboprophylaxis improves the live birth rate in women with consecutive recurrent miscarriages and hereditary thrombophilia. J Thromb Haemost 2003; 1:433-438. This study, performed in women with recurrent misscarriage, found significant benefit in primary aborters with LMWH when compared with untreated control women.
20. Paidas M, Ku DH, Triche E, et al. Does heparin therapy improve pregnancy outcome in patients with thrombophilias? J Thromb Haemost 2004; 2:1194-1195. Outcomes of subsequent and previous pregnancies in the same women were compared.
21. Gris JC, Mercier E, Quere I, et al. Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder. Blood 2004; 103:3695-3699. This study compared the use of LMWH and LDA in women with inherited thrombophilias but the women had one previous loss only.
22. Rai R, Tuddenham E, Backos M, et al. Thromboelastography, whole-blood haemostasis and recurrent miscarriage. Hum Reprod 2003; 18: 2540-2543.
23. Chamley LW, Duncalf AM, Mitchell MD, Johnson PM. Action of anticardiolipin and antibodies to beta2-glycoprotein-I on trophoblast proliferation as a mechanism for fetal death. Lancet 1998; 352:1037-1038.
24. 2-glycoprotein-I antibody binding to trophoblast cells is shown to down-regulate trophoblast human chorionic gonadotrophin synthesis and secretion. The authors suggest that this may be a mechanism of defective placentation in women with APS-related fetal loss.
25. Di Simone N, Caliandro D, Castellani R, et al. Low-molecular weight heparin restores in-vitro trophoblast invasiveness and differentiation in presence of immunoglobulin G fractions obtained from patients with antiphospholipid syndrome. Hum Reprod 1999; 14:489-495.
26. Kutteh WH. Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol 1996; 174:1584-1589.
27. Rai R, Cohen H, Dave M, Regan L. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ 1997; 314:253-257.
28. Empson M, Lassere M, Craig JC, Scott JR. Recurrent pregnancy loss with antiphospholipid antibody: a systematic review of therapeutic trials. Obstet Gynecol 2002; 99:135-144.
29. Farquharson RG, Quenby S, Greaves M. Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment. Obstet Gynecol 2002; 100:408-413.
30. Rai R, Regan L. Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment [letter]. Obstet Gynecol 2002; 100:1354.
31. Kutteh WH. Antiphospholipid syndrome in pregnancy [letter]. Obstet Gynecol 2002; 100:1354; author reply 1354-1356.
32. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004; 81:19-25. This is an informative article providing an update on the diagnostic criteria and management of PCOS.
33. Balen AH, Tan SL, MacDougall J, Jacobs HS. Miscarriage rates following in-vitro fertilization are increased in women with polycystic ovaries and reduced by pituitary desensitization with buserelin. Hum Reprod 1993; 8:959-964.
34. Clifford K, Rai R, Watson H, et al. Does suppressing luteinising hormone secretion reduce the miscarriage rate? Results of a randomised controlled trial. BMJ 1996; 312:1508-1511.
35. Liddell HS, Sowden K, Farquhar CM. Recurrent miscarriage: screening for polycystic ovaries and subsequent pregnancy outcome. Aust N Z J Obstet Gynaecol 1997; 37:402-406.
36. Nardo LG, Rai R, Backos M, et al. High serum luteinizing hormone and testosterone concentrations do not predict pregnancy outcome in women with recurrent miscarriage. Fertil Steril 2002; 77:348-352.
37. Rai R, Backos M, Rushworth F, Regan L. Polycystic ovaries and recurrent miscarriage: a reappraisal. Hum Reprod 2000; 15:612-615.
38. Franks S, Gilling-Smith C, Watson H, Willis D. Insulin action in the normal and polycystic ovary. Endocrinol Metab Clin North Am 1999; 28:361-378.
39. Craig LB, Ke RW, Kutteh WH. Increased prevalence of insulin resistance in women with a history of recurrent pregnancy loss. Fertil Steril 2002; 78:487-490.
40. Rai R. Is miscarriage a coagulopathy? Curr Opin Obstet Gynecol 2003; 15:265-268.
41. Jakubowicz DJ, Seppala M, Jakubowicz S, et al. Insulin reduction with metformin increases luteal phase serum glycodelin and insulin-like growth factor-binding protein 1 concentrations and enhances uterine vascularity and blood flow in the polycystic ovary syndrome. J Clin Endocrinol Metab 2001; 86:1126-1133.
42. Tulppala M, Julkunen M, Tiitinen A, et al. Habitual abortion is accompanied by low serum levels of placental protein 14 in the luteal phase of the fertile cycle. Fertil Steril 1995; 63:792-795.
43. Dalton CF, Laird SM, Serle E, et al. The measurement of CA 125 and placental protein 14 in uterine flushings in women with recurrent miscarriage; relation to endometrial morphology. Hum Reprod 1995; 10:2680-2684.
44. Jones JI, Gockerman A, Busby WH Jr, et al. Insulin-like growth factor binding protein 1 stimulates cell migration and binds to the alpha 5 beta 1 integrin by means of its Arg-Gly-Asp sequence. Proc Natl Acad Sci USA 1993; 90:10553-10557.
45. Giudice LC, Mark SP, Irwin JC. Paracrine actions of insulin-like growth factors and IGF binding protein-1 in non-pregnant human endometrium and at the decidual-trophoblast interface. J Reprod Immunol 1998; 39:133-148.
46. Suikkari AM, Ruutiainen K, Erkkola R, Seppala M. Low levels of low molecular weight insulin-like growth factor-binding protein in patients with polycystic ovarian disease. Hum Reprod 1989; 4:136-139.
47. Ben-Haroush A, Yogev Y, Fisch B. Insulin resistance and metformin in polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol 2004; 115:125-133. This article gives a comprehensive update on the effects of insulin resistance on the reproductive system and evaluates the use of metformin in treating symptomatic women with PCOS.
48. Jakubowicz DJ, Essah PA, Seppala M, et al. Reduced serum glycodelin and insulin-like growth factor-binding protein-1 in women with polycystic ovary syndrome during first trimester of pregnancy. J Clin Endocrinol Metab 2004; 89:833-839. This study presents a possible mechanism for early miscarriage in PCOS.
49. Jakubowicz DJ, Seppala M, Jakubowicz S, et al. Insulin reduction with metformin increases luteal phase serum glycodelin and insulin-like growth factor-binding protein 1 concentrations and enhances uterine vascularity and blood flow in the polycystic ovary syndrome. J Clin Endocrinol Metab 2001; 86:1126-1133.
50. Fedorcsak P, Dale PO, Storeng R, et al. Impact of overweight and under-weight on assisted reproduction treatment. Hum Reprod 2004 [Epub ahead of print]. This study leads to the conclusion that obesity has a negative impact on the live birth rate following assisted reproduction.
51. Bellver J, Rossal LP, Bosch E, et al. Obesity and the risk of spontaneous abortion after oocyte donation. Fertil Steril 2003; 79:1136-1140.
52. Lashen H, Fear K, Sturdee DW. Obesity is associated with increased risk of first trimester and recurrent miscarriage: matched case-control study. Hum Reprod 2004; 19:1644-1646. This is a large case-control study showing a significant association between obesity and spontaneous miscarriage. Gestational diabetes was more prevalent in the obese subjects, suggesting a link between insulin resistance and spontaneous miscarriage.
53. Trundley A, Moffett A. Human uterine leukocytes and pregnancy. Tissue Antigens 2004; 63:1-12. This review article covers immunological changes which occur at the site of implantation.
54. + natural killer cells in women with recurrent miscarriage: a histomorphometric study. Hum Reprod 1999; 14:2727-2730.
55. Quenby S, Bates M, Doig T, et al. Pre-implantation endometrial leukocytes in women with recurrent miscarriage. Hum Reprod 1999; 14:2386-2391.
56. 56_ Lachapelle MH, Miron P, Hemmings R, Roy DC. Endometrial T, B, and NK cells in patients with recurrent spontaneous abortion. Altered profile and pregnancy outcome. J Immunol 1996; 156:4027-4034.
57. + dendritic cells in the decidua of women with recurrent miscarriage and normal pregnancy. Placenta 2004; 25:140-145. In this study, the dendritic cell density of the uterine decidua is shown to be significantly increased in some cases of early recurrent miscarriage.
58. Aoki K, Kajiura S, Matsumoto Y, et al. Preconceptional natural-killer-cell activity as a predictor of miscarriage. Lancet 1995; 345:1340-1342.
59. Kwak JY, Kwak FM, Ainbinder SW, et al. Elevated peripheral blood natural killer cells are effectively downregulated by immunoglobulin G infusion in women with recurrent spontaneous abortions. Am J Reprod Immunol 1996; 35:363-369.
60. Beer AE, Kwak JY, Ruiz JE. Immunophenotypic profiles of peripheral blood lymphocytes in women with recurrent pregnancy losses and in infertile women with multiple failed in vitro fertilization cycles. Am J Reprod Immunol 1996; 35:376-382.
61. Emmer PM, Nelen WL, Steegers EA, et al. Peripheral natural killer cytotoxicity and CD56(pos)CD16(pos) cells increase during early pregnancy in women with a history of recurrent spontaneous abortion. Hum Reprod 2000; 15:1163-1169.
62. Ntrivalas EI, Kwak-Kim JY, Gilman-Sachs A, et al. Status of peripheral blood natural killer cells in women with recurrent spontaneous abortions and infertility of unknown aetiology. Hum Reprod 2001; 16:855-861.
63. Souza SS, Ferriani RA, Santos CM, Voltarelli JC. Immunological evaluation of patients with recurrent abortion. J Reprod Immunol 2002; 56:111-121.
64. Yamada H, Morikawa M, Kato EH, et al. Pre-conceptional natural killer cell activity and percentage as predictors of biochemical pregnancy and spontaneous abortion with normal chromosome karyotype. Am J Reprod Immunol 2003; 50:351-354.
65. Shakhar K, Ben-Eliyahu S, Loewenthal R, et al. Differences in number and activity of peripheral natural killer cells in primary versus secondary recurrent miscarriage. Fertil Steril 2003; 80:368-375.
66. - cells in total natural killer cells as an indication of fertility and infertility. Fertil Steril 2003; 80 (suppl 2):691-697.
67. Gilman-Sachs A, DuChateau BK, Aslakson CJ, et al. Natural killer (NK) cell subsets and NK cell cytotoxicity in women with histories of recurrent spontaneous abortions. Am J Reprod Immunol 1999; 41:99-105.
68. + NK cells in the peripheral blood is associated with a poorer IVF treatment and pregnancy outcome. Hum Reprod 2004; 19:2395-2400. This is a prospective study of women undergoing IVF treatment. Those with peripherally elevated CD56dimCD16+CD69+ natural killer cells had a significantly lower embryo implantation rate and higher miscarriage rate than women with lower counts.
69. Yovel G, Shakhar K, Ben-Eliyahu S. The effects of sex, menstrual cycle, and oral contraceptives on the number and activity of natural killer cells. Gynecol Oncol 2001; 81:254-262.
70. Quenby S, Farquharson R, Young M, Vince G. Successful pregnancy outcome following 19 consecutive miscarriages: case report. Hum Reprod 2003; 18:2562-2564.
71. Laskin CA, Bombardier C, Hannah ME, et al. Prednisone and aspirin in women with autoantibodies and unexplained recurrent fetal loss. N Engl J Med 1997; 337:148-153.
72. Cowchock FS, Reece EA, Balaban D, et al. Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment. Am J Obstet Gynecol 1992; 166:1318-1323.
73. Billingham RE, Brent L, Medawar PB. 'Actively acquired tolerance' of foreign cells. 1953. Transplantation 2003; 76:1409-1412.
74. Wegmann TG, Lin H, Guilbert L, Mosmann TR. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? Immunol Today 1993; 14:353-356.
75. Marzi M, Vigano A, Trabattoni D, et al. Characterization of type 1 and type 2 cytokine production profile in physiologic and pathologic human pregnancy. Clin Exp Immunol 1996; 106:127-133.
76. Raghupathy R, Makhseed M, Azizieh F, et al. Cytokine production by maternal lymphocytes during normal human pregnancy and in unexplained recurrent spontaneous abortion. Hum Reprod 2000; 15:713-718.
77. Makhseed M, Raghupathy R, Azizieh F, et al. Th1 and Th2 cytokine profiles in recurrent aborters with successful pregnancy and with subsequent abortions. Hum Reprod 2001; 16:2219-2226.
78. Wilson R, Jenkins C, Miller H, et al. Abnormal cytokine levels in non-pregnant women with a history of recurrent miscarriage. Eur J Obstet Gynecol Reprod Biol 2004; 115:51-54. Prepregnant interferon-γ and interleukin-12 levels were found to be higher and interleukin-18 lower in women with at least three miscarriages compared with women with no such history. A subsequent miscarriage was associated with a higher interleukin-18 in the prepregnant state.
79. Kruse C, Varming K, Christiansen OB. Prospective, serial investigations of in-vitro lymphocyte cytokine production, CD62L expression and proliferative response to microbial antigens in women with recurrent miscarriage. Hum Reprod 2003; 18:2465-2472.
80. Shimada S, Iwabuchi K, Kato EH, et al. No difference in natural-killer-T cell population, but Th2/Tc2 predominance in peripheral blood of recurrent aborters. Am J Reprod Immunol 2003; 50:334-339.
81. Sacks GP, Redman CW, Sargent IL. Monocytes are primed to produce the Th1 type cytokine IL-12 in normal human pregnancy: an intracellular flow cytometric analysis of peripheral blood mononuclear cells. Clin Exp Immunol 2003; 131:490-497.
82. Chaouat G, Ledee-Bataille N, Dubanchet S, et al. Reproductive immunology 2003: reassessing the Th1/Th2 paradigm? Immunol Lett 2004; 92:207-214.
83. Sacks GP, Seyani L, Lavery S, Trew G. Maternal C-reactive protein levels are raised at 4 weeks gestation. Hum Reprod 2004; 19:1025-1030. This study suggests that activation of innate immunity occurs or is required during the earliest phases of embryo implantation.
84. Mikolajczyk M, Skrzypczak J, Szymanowski K, Wirstlein P. The assessment of LIF in uterine flushing: a possible new diagnostic tool in states of impaired fertility. Reprod Biol 2003; 3:259-270.